1. 2109 Anti-EGFR or Bevacizumab in first line treatment of RAS wild type metastatic colorectal neoplasm (RwtMCRC): pooled analysis of randomized clincal trials. (September 2015) Authors: Tamburini, E.; Gianni, L.; Pasini, G.; Papi, M.; Stocchi, L.; Rudnas, B.; Affatato, A.; Drudi, F.; Nicoletti, S.; Santelmo, C.; Ridolfi, C.; Fantini, M.; Tassinari, D. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S365 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Are strong opioids equally effective and safe in the treatment of chronic cancer pain? A multicenter randomized phase IV 'real life' trial on the variability of response to opioids. (2nd March 2016) Authors: Corli, O.; Floriani, I.; Roberto, A.; Montanari, M.; Galli, F.; Greco, M. T.; Caraceni, A.; Kaasa, S.; Dragani, T. A.; Azzarello, G.; Luzzani, M.; Cavanna, L.; Bandieri, E.; Gamucci, T.; Lipari, G.; Di Gregorio, R.; Valenti, D.; Reale, C.; Pavesi, L.; Iorno, V. Journal: Annals of oncology Issue: Volume 27:Number 6(2016:Jun.) Page Start: 1107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗